Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated

See also
Status	Clinical Trial	Phase
Completed	`NCT06136975` - Low-level Laser Therapy for Genitourinary Syndromes and Stress Urinary Incontinence
Recruiting	`NCT04081805` - LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)	N/A
Completed	`NCT04039555` - Clinical Study to Compare the Efficacy of Erbium-Yag Laser or CO2RE Intimate Laser With Sham (COER)	N/A
Active, not recruiting	`NCT02704741` - Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments	N/A
Completed	`NCT01975129` - A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin	Phase 2
Completed	`NCT04735549` - Vulvovaginal Atrophy Correction Using Neodymium Laser	N/A
Completed	`NCT04079218` - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial	Phase 4
Completed	`NCT03063684` - Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus	N/A
Recruiting	`NCT05953090` - VALOR: Vaginal Atrophy & Long-term Observation of Recovery	N/A
Not yet recruiting	`NCT05483634` - Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause
Completed	`NCT04717245` - Comparative Study: Vaginal Promestriene Use, Fractional CO2 LASER and Radiofrequency in the Vaginal Atrophy Treatment	N/A
Completed	`NCT02937805` - Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes	N/A
Completed	`NCT02967510` - Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy	Phase 2
Not yet recruiting	`NCT02571127` - Evaluate the Efficacy, Safety and Tolerability of a Non-hormonal Intravaginal Gel in Postmenopausal Women With Symptoms of Vaginal Dryness.	Phase 4
Completed	`NCT00238732` - Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause	Phase 3
Completed	`NCT02413008` - A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting	Phase 2
Completed	`NCT03493126` - Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function	Phase 4
Not yet recruiting	`NCT03238053` - Laser Treatment of Genito-urinary Syndrome in Women	N/A
Terminated	`NCT01753102` - Efficacy and Safety Of Spil's Estradiol Vaginal Tablet	Phase 3
Terminated	`NCT05627791` - Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman	Phase 2/Phase 3

NCT number	NCT02013544
Study type	Interventional
Source	EndoCeutics Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	February 2014
Completion date	February 2015

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms